Persistent concerns that Alphabet Inc. has fallen behind in the artificial intelligence supremacy race has weighed on the ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

AI has the potential to revolutionize everything from the way you plan your day, thanks to AI assistants, to the way ...

Alphabet's forward P/E is historically low and 28.11% below Nasdaq's, making it an attractive buy at current levels. Click ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Alphabet's (GOOGL.O) this week unveiled its seventh-generation artificial intelligence chip named Ironwood, which the company ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...